BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 6138646)

  • 1. Aberrant expression of HLA-DR antigen on thyrocytes in Graves' disease: relevance for autoimmunity.
    Hanafusa T; Pujol-Borrell R; Chiovato L; Russell RC; Doniach D; Bottazzo GF
    Lancet; 1983 Nov; 2(8359):1111-5. PubMed ID: 6138646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoimmune thyroid disease--a perspective.
    Volpé R
    Mol Biol Med; 1986 Feb; 3(1):25-51. PubMed ID: 2870410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Class II major histocompatibility complex antigen expression and cellular interactions in thyroid glands of Graves' disease.
    Matsunaga M; Eguchi K; Fukuda T; Kurata A; Tezuka H; Shimomura C; Otsubo T; Ishikawa N; Ito K; Nagataki S
    J Clin Endocrinol Metab; 1986 Apr; 62(4):723-8. PubMed ID: 3081570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrathyroidal HLA-DR expression and T lymphocyte phenotypes in Graves' thyrotoxicosis, Hashimoto's thyroiditis and nodular colloid goitre.
    Jansson R; Karlsson A; Forsum U
    Clin Exp Immunol; 1984 Nov; 58(2):264-72. PubMed ID: 6238731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interaction of MHC and Gm in liability to autoimmune thyroid disease.
    Nagataki S
    Mol Biol Med; 1986 Feb; 3(1):73-84. PubMed ID: 3007922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [An immunohistochemical study on human leucocyte antigen-DR in Hashimoto thyroiditis and Graves disease].
    Zhang H; Li D; Ouyang A
    Zhonghua Nei Ke Za Zhi; 1996 May; 35(5):303-5. PubMed ID: 9387612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity.
    Bottazzo GF; Pujol-Borrell R; Hanafusa T; Feldmann M
    Lancet; 1983 Nov; 2(8359):1115-9. PubMed ID: 6138647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Occurrence of thyrocyte HLA class II expression in a wide variety of thyroid diseases: relationship with lymphocytic infiltration and thyroid autoantibodies.
    Lucas-Martin A; Foz-Sala M; Todd I; Bottazzo GF; Pujol-Borrell R
    J Clin Endocrinol Metab; 1988 Feb; 66(2):367-75. PubMed ID: 3276724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmune and non-autoimmune thyroid diseases have different patterns of cellular HLA class II expression.
    Zantut-Wittmann DE; Boechat LH; Pinto GA; da Silva Trevisan MA; Vassallo J
    Sao Paulo Med J; 1999 Jul; 117(4):161-4. PubMed ID: 10559851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In situ immune complexes, lymphocyte subpopulations, and HLA-DR-positive epithelial cells in Hashimoto thyroiditis.
    Aichinger G; Fill H; Wick G
    Lab Invest; 1985 Feb; 52(2):132-40. PubMed ID: 3881622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The in vitro regulation of human thyrocyte HLA-DR antigen expression.
    Weetman AP; Volkman DJ; Burman KD; Gerrard TL; Fauci AS
    J Clin Endocrinol Metab; 1985 Nov; 61(5):817-24. PubMed ID: 2995430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of intercellular adhesion molecule-1 in thyroid follicular cells in autoimmune, non-autoimmune and neoplastic diseases of the thyroid gland: discordance with HLA.
    Tolosa E; Roura C; Catálfamo M; Martí M; Lucas-Martín A; Sanmartí A; Salinas I; Obiols G; Foz-Sala M; Pujol-Borrell R
    J Autoimmun; 1992 Feb; 5(1):107-18. PubMed ID: 1348415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intercellular adhesion molecule-1 (ICAM-1) in Graves' disease: contrast between in vivo and in vitro results.
    Ciampolillo A; Napolitano G; Mirakian R; Miyasaki A; Giorgino R; Bottazzo GF
    Clin Exp Immunol; 1993 Dec; 94(3):478-85. PubMed ID: 7902787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-DR antigen expression on intrathyroidal lymphocytes and thyrocytes in Hashimoto's thyroiditis and Graves' disease: an immunohistological study.
    Misaki T; Konishi J; Arai K; Iida Y; Kasagi K; Kuma K; Torizuka K
    Endocrinol Jpn; 1987 Apr; 34(2):257-62. PubMed ID: 3113922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localization of HLA-DR alpha-chain messenger ribonucleic acid in normal and autoimmune human thyroid using in situ hybridization.
    Piccinini LA; Goldsmith NK; Schachter BS; Davies TF
    J Clin Endocrinol Metab; 1988 Jun; 66(6):1307-15. PubMed ID: 2453529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of intercellular adhesion molecule-1 (ICAM-1) on thyroid epithelial cells in Hashimoto's thyroiditis but not in Graves' disease or papillary thyroid cancer.
    Bagnasco M; Caretto A; Olive D; Pedini B; Canonica GW; Betterle C
    Clin Exp Immunol; 1991 Feb; 83(2):309-13. PubMed ID: 1671565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro cellular interactions among thyrocytes, T cells and monocytes from patients with Graves' disease.
    Otsubo T; Eguchi K; Shimomura C; Ueki Y; Tezuka H; Ishikawa N; Ito K; Nagataki S
    Acta Endocrinol (Copenh); 1988 Mar; 117(3):282-8. PubMed ID: 3132793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyrocyte HLA-DR expression and interferon-gamma production in autoimmune thyroid disease.
    Iwatani Y; Gerstein HC; Iitaka M; Row VV; Volpé R
    J Clin Endocrinol Metab; 1986 Sep; 63(3):695-708. PubMed ID: 3090094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coexpression of CD40 and class II antigen HLA-DR in Graves' disease thyroid epithelial cells.
    Faure GC; Bensoussan-Lejzerowicz D; Bene MC; Aubert V; Leclere J
    Clin Immunol Immunopathol; 1997 Aug; 84(2):212-5. PubMed ID: 9245555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-polarized cell surface expression of HLA-A,B,C and HLA-DR antigens in Graves' thyroid follicle cells.
    Mölne J; Nilsson M; Jansson S; Hansson G; Ericson LE
    Autoimmunity; 1991; 10(3):189-99. PubMed ID: 1756224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.